Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

Read about a family's journey through pediatric heart surgery at Johns Hopkins All Children's, where expert care gave baby ...

When doctors feel unable to provide the care they believe is best for their patients, they may experience what bioethicists ...